# Fly-E Group, Inc.: overview FLYE · Nasdaq · CIK 1975940 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/flye.md) · [Financials](/companies/flye/financials.md) · [Filings](/companies/flye/filings.md) · [Insiders](/companies/flye/insiders.md) Latest reported revenue: [$2.7m](/filings/0001213900-26-096305.md) for Q1 FY2027, three months to 2026-06-30, from the 10-Q filed Sep 1, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-096305). ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [6,824](/filings/0001213900-25-123281.md) | [5,678](/filings/0001213900-26-046242.md) | [5,051 d](/filings/0001213900-26-080973.md) | [5,328](/filings/0001213900-26-096305.md) | [3,909](/filings/0001213900-25-123281.md) | [2,649](/filings/0001213900-26-046242.md) | [7,177 d](/filings/0001213900-26-080973.md) | [2,748](/filings/0001213900-26-096305.md) | | Gross margin | % | [42.6%](/filings/0001213900-25-123281.md) | [45.1%](/filings/0001213900-26-046242.md) | [37.3% d](/filings/0001213900-26-080973.md) | [42.4%](/filings/0001213900-26-096305.md) | [25.0%](/filings/0001213900-25-123281.md) | [39.6%](/filings/0001213900-26-046242.md) | [5.2% d](/filings/0001213900-26-080973.md) | [10.9%](/filings/0001213900-26-096305.md) | | Operating margin | % | [(18.0%)](/filings/0001213900-25-123281.md) | [(16.6%)](/filings/0001213900-26-046242.md) | [(46.4%) d](/filings/0001213900-26-080973.md) | [(28.2%)](/filings/0001213900-26-096305.md) | [(26.8%)](/filings/0001213900-25-123281.md) | [(58.8%)](/filings/0001213900-26-046242.md) | [(32.4%) d](/filings/0001213900-26-080973.md) | [(128.7%)](/filings/0001213900-26-096305.md) | | Net margin | % | [(16.7%)](/filings/0001213900-26-046242.md) | [(12.1%)](/filings/0001213900-26-046242.md) | [(65.0%) d](/filings/0001213900-26-080973.md) | [(37.7%)](/filings/0001213900-26-096305.md) | [(45.4%)](/filings/0001213900-26-046242.md) | [(72.6%)](/filings/0001213900-26-046242.md) | [(49.5%) d](/filings/0001213900-26-080973.md) | [(143.3%)](/filings/0001213900-26-096305.md) | | Diluted EPS | $ per share | not reported | [(2.78)](/filings/0001213900-26-046242.md) | not reported | [(6.00)](/filings/0001213900-26-096305.md) | not reported | [(1.18)](/filings/0001213900-26-046242.md) | not reported | [(2.41)](/filings/0001213900-26-096305.md) | | Free cash flow | $k | [(6,114) d](/filings/0001213900-25-123281.md) | [(44.2) d](/filings/0001213900-26-046242.md) | [(661) d](/filings/0001213900-26-080973.md) | [(5,426)](/filings/0001213900-26-096305.md) | [(2,520) d](/filings/0001213900-25-123281.md) | [(6,289) d](/filings/0001213900-26-046242.md) | [116 d](/filings/0001213900-26-080973.md) | [(192)](/filings/0001213900-26-096305.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | [21.8](/filings/0001213900-24-056786.md) | [32.2](/filings/0001213900-25-064293.md) | [25.4](/filings/0001213900-26-080973.md) | [19.1](/filings/0001213900-26-080973.md) | | Gross margin | % | [38.1%](/filings/0001213900-24-056786.md) | [40.7%](/filings/0001213900-25-064293.md) | [41.1%](/filings/0001213900-26-080973.md) | [24.4%](/filings/0001213900-26-080973.md) | | Operating margin | % | [10.6%](/filings/0001213900-24-056786.md) | [10.1%](/filings/0001213900-25-064293.md) | [(17.9%)](/filings/0001213900-26-080973.md) | [(33.8%)](/filings/0001213900-26-080973.md) | | Net margin | % | [6.3%](/filings/0001213900-24-056786.md) | [5.9%](/filings/0001213900-25-064293.md) | [(20.8%)](/filings/0001213900-26-080973.md) | [(48.6%)](/filings/0001213900-26-080973.md) | | Diluted EPS | $ per share | not reported | not reported | [(21.95)](/filings/0001213900-26-080973.md) | [(8.38)](/filings/0001213900-26-080973.md) | | Free cash flow | $m | not reported | [3.1](/filings/0001213900-25-064293.md) | [(11.7)](/filings/0001213900-26-080973.md) | [(13.9)](/filings/0001213900-26-080973.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/flye/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $31.0k | 14,702 | | New +14,702 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $27.5k | 13,015 | | Reduced −13,208 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $22.6k | 10,714 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $14.9k | 7,066 | | Unchanged | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $3.7k | 1,763 | | Reduced −1,147 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $460 | 218 | | New +218 | | [HRT FINANCIAL LP](/funds/1475597.md) | 2026-06-30 | $41 | 19,442 | | New +19,442 | ## Recent filings [All 111 filings](/companies/flye/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-14 | 17:01 ET | [8-K/A](/filings/0001213900-26-099774.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-099774 | | 2026-09-11 | 17:29 ET | [8-K](/filings/0001213900-26-099368.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-099368 | | 2026-09-03 | 17:00 ET | [8-K](/filings/0001213900-26-097254.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-097254 | | 2026-09-01 | 17:23 ET | [10-Q](/filings/0001213900-26-096305.md) | Quarterly report, period 2026-06-30 | 0001213900-26-096305 | | 2026-07-29 | 17:28 ET | [8-K](/filings/0001213900-26-082915.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-082915 | | 2026-07-23 | 17:15 ET | [8-K](/filings/0001213900-26-080994.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-080994 | | 2026-07-23 | 17:00 ET | [10-K](/filings/0001213900-26-080973.md) | Annual report, period 2026-03-31 | 0001213900-26-080973 | | 2026-06-17 | 17:00 ET | [8-K](/filings/0001213900-26-069700.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-069700 | | 2026-05-26 | 17:00 ET | [DEF 14A](/filings/0001213900-26-061076.md) | Proxy statement, period 2026-06-17 | 0001213900-26-061076 | | 2026-04-27 | 17:00 ET | [8-K](/filings/0001213900-26-048067.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-048067 | ## Latest annual report [Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001213900-26-080973.md), filed Jul 23, 2026. ## Forecast league Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/b0ba65ba-b1df-4b27-8a60-e43b0182a08c) ## About the filer - CIK: 1975940 - Tickers: FLYE - Exchange: Nasdaq - SIC code: 3711 Motor Vehicles & Passenger Car Bodies - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 17:05 ET. No prices; not investment advice.